4//SEC Filing
BELLICUM PHARMACEUTICALS, INC 4
Accession 0001209191-14-077802
CIK 0001358403operating
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 5:25 PM ET
Size
14.8 KB
Accession
0001209191-14-077802
Insider Transaction Report
Form 4
BROWN JAMES F
Director
Transactions
- Conversion
Common Stock
2014-12-23+679,650→ 679,650 total(indirect: By AVG Ventures, LP) - Conversion
Series B Convertible Preferred Stock
2014-12-23−1,155,405→ 0 total(indirect: By AVG Ventures, LP)→ Common Stock (679,650 underlying) - Conversion
Series C Convertible Preferred Stock
2014-12-23−344,033→ 0 total(indirect: By AVG Ventures, LP)→ Common Stock (202,372 underlying) - Conversion
Common Stock
2014-12-23+202,372→ 882,022 total(indirect: By AVG Ventures, LP) - Other
Common Stock
2014-12-23+23,300→ 905,322 total(indirect: By AVG Ventures, LP)
Footnotes (5)
- [F1]The Reporting Person is the manager of AVG Ventures GP, LLC, which is general partner of AVG Ventures, LP, which owns the reported securities. The Reporting Person shares voting and investment power with respect to shares held by AVG Ventures, LP. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- [F2]Reflects 1.7-for-1 reverse stock split which became effective on December 5, 2014.
- [F3]The Series B Convertible Preferred Stock converted into the Issuer's common stock on a 1.7-for-1 basis and had no expiration date.
- [F4]The Series C Convertible Preferred Stock converted into the Issuer's common stock on a 1.7-for-1 basis and had no expiration date.
- [F5]On December 4, 2014, the Board of Directors of the Issuer declared a dividend payable to all holders of records of the Series B Convertible Participating Preferred Stock of the Issuer on December 16, 2014, payable in the form of cash or in shares of Common Stock of the Issuer, at the option of each holder. The dividends occurred in connection with the closing of the Issuer's public offering. The Reporting Person elected to receive the shares of Common Stock.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeoperating
Related Parties
1- filerCIK 0001358403
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 5:25 PM ET
- Size
- 14.8 KB